Validation of a Spanish version of a chronic pancreatitis assessment tool
Validation of COMPAT-SF Spanish Translation
This study is testing a Spanish version of a tool to help understand the experiences of people with chronic pancreatitis to make sure it works well for Spanish-speaking patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Methodist Health System Academic / other |
| Locations | 1 site (Dallas, Texas) |
| Trial ID | NCT06698302 on ClinicalTrials.gov |
What this trial studies
This observational study aims to validate a Spanish-translated version of the COMPAT-SF instrument for chronic pancreatitis patients. It will collect data from Spanish-speaking patients at Methodist Dallas Medical Center from June 2024 to July 2027. Participants will complete questionnaires to assess the effectiveness of the translation in capturing patient experiences. The study focuses on ensuring that the instrument is culturally and linguistically appropriate for Spanish-speaking populations.
Who should consider this trial
Good fit: Ideal candidates are Spanish-speaking adults aged 18 and older with a confirmed diagnosis of chronic pancreatitis and stable pain patterns.
Not a fit: Patients who are not Spanish-speaking or who have unstable pain patterns may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the assessment and management of chronic pancreatitis in Spanish-speaking patients.
How similar studies have performed: While this specific translation validation approach is relatively novel, similar studies have successfully validated translated medical instruments in other populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years or older in age * Have a definite CP diagnosis and a stable pain pattern with no new interventions or medications in the last three months * Able to read and understand the study information in Spanish * Personally signed and dated ICF indicating that the subject has been informed of all pertinent aspects of the study * Subject is willing and able to comply with the scheduled questionnaires Exclusion Criteria: * Subjects who do not meet the criteria in section 4.1
Where this trial is running
Dallas, Texas
- Methodist Dallas Medical Center- Clinical Research Institute — Dallas, Texas, United States (Recruiting)
Study contacts
- Study coordinator: Jeff Wilson
- Email: JeffreyWilson@mhd.com
- Phone: 2149471279
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.